直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

“Follow-On” Petitions Have Significant Hurdles to Overcome

March 31, 2015

Authored and Edited by Anthony A. Hartmann; Maureen D. Queler

The PTAB denied Petitioner’s request for rehearing of a decision declining to institute an IPR in Conopco Inc. dba Unilever v. The Proctor & Gamble Co., IPR2014-00628, Paper 23 (March 20, 2015). This was Unilever’s second petition against the same patent. See IPR2013-00510, Paper 2. The petition was denied in-part for raising “substantially the same prior art or argument” presented in the first petition. Paper 23 at 3 (citing 35 U.S.C. §325(d)).

In denying institution, the PTAB identified several factors: (1) Unilever’s second petition failed to address §325(d) or compare its prior art and arguments against the earlier petition; (2) while the second petition presented different prior art, it applied the same arguments for anticipation and obviousness; (3) some prior art in the second petition was previously considered by the Office during prosecution or in the first petition; and (4) Unilever failed to argue that the newly cited prior art “were unknown or unavailable” when the first petition was filed, leading to “a reasonable inference that those references were known and available” at the time. IPR2014-00628, Paper 21, at 5-6, 8, 10-11.

In denying rehearing, the PTAB argued that Unilever failed to show an abuse of discretion. IPR2014-00628, Paper 23, at 3. Unilever argued that the statutes and rules do not preclude a second petition; however, the PTAB noted that 35 U.S.C. §314 provides the discretion to deny the second petition. Paper 23 at 4. Specifically, the PTAB may, but not must, institute an IPR when a party demonstrates a reasonable likelihood to prevail. Paper 23 at 4.

Unilever also argued that PTAB should not have applied the “known or available” standard, arguing that petitioners should be able to file “follow-on” petitions to correct deficiencies noted by the PTAB. Paper 23 at 5. The PTAB found no rationale to support Unilever’s position, noting that it would “tax Board resources and force patent owners to defend multiple attacks.” Paper 23 at 5. Unilver further argued that the decision was an abuse of discretion because there were differences between the sets of prior art. Paper 23 at 6. The PTAB recognized these differences, but concluded that the art and arguments were nonetheless “substantially the same.” Paper 23 at 6.

This decision puts petitioners on notice that if they are considering a “follow-on” petition, they need to be able to address 35 U.S.C. §325(d) and compare the prior art and arguments between the petitions, explain how the prior art and arguments in the petitions are not “substantially the same,” and explain how the newly cited art was not previously “known or available.” Otherwise, there is a risk that the petition will be rejected, despite the merits of the arguments.

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Contacts

Anthony A. Hartmann
Of Counsel
Washington, DC
+1 202 408 4275
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Virtual Seminar

Privacy on Purpose

September 30, 2026

Virtual

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: August 2026

September 29, 2026

INCONTESTABLE® Blog

Finding a Lack of Bona Fide Use, TTAB Affirms Cancellation of Everwise Credit Union Registration Under the Lanham Act’s Reexamination Procedure

September 24, 2026

Articles

Trade Secret Litigation Checklist for Defendants

September/October 2026

Articles

Updates on Export Controls Impacting AI & Advanced Computing

September 21, 2026

Conference

42nd Annual Fall Institute on Intellectual Property Law

September 17-19, 2026

Galveston

Federal Circuit IP Blog

Staying True to the Specification: Federal Circuit Vacates Preliminary Injunction Based on Unsupported Claim Constructions

September 16, 2026

At the PTAB Blog

The Proof Is in the Priority: Director Squires Addresses Antedating and Prior-Art Qualification

September 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP